Why did ZBH.SW stock drop intraday to CHF67.50

The intraday drop to **CHF67.50** reflects short-term selling pressure, weak momentum, and positioning ahead of earnings on 10 Feb 2026. Low intraday liquidity and technical gap moves amplified the decline.

Is ZBH.SW stock a buy after the oversold signal

An oversold RSI (**18.81**) can signal a bounce. Short-term traders may buy on confirmation above **CHF75.00**. Long-term buyers should weigh Meyka AI forecasts and fundamentals before adding exposure.

What price targets should traders use for ZBH.SW stock

Use a conservative rebound target at **CHF78.58** (50-day average) and a stop below **CHF67.50**. Meyka AI's yearly model target is **CHF56.70**, which implies downside for longer horizons.

How does Zimmer Biomet compare to the healthcare sector

Zimmer Biomet trades at **PE 21.50**, below the Healthcare sector average **PE 34.55**. The company has stronger free cash flow yield but faces margin pressure and leverage relative to peers.

CH Stocks

ZBH.SW Zimmer Biomet SIX CHF67.50 intraday 06 Feb 2026: Oversold bounce watch

ByHuzaifa Zahoor February 6, 2026

ZBH.SW stock dropped to CHF67.50 intraday on SIX on 06 Feb 2026, down 4.26% from yesterday and hitting the session low. The sell-off pushed the RSI to 18.81, a clear oversold reading that often precedes a technical bounce. We track volume of 110 shares and compare the price to the 50-day average CHF78.58 and 200-day average CHF87.90 to frame a short-term rebound trade. This intraday note focuses on catalyst, technical setup, and model-driven price scenarios